Website title:When comic strip creator Scott Adams called out for help, former President Donald Trump answered without hesitation.

Adams, best known as the mind behind "Dilbert," is battling an aggressive spread of prostate cancer and reached out publicly after delays in securing crucial treatment—prompting Trump to step in and attempt to expedite care, as The Hill reports.

In a direct post on Truth Social, Trump responded to Adams’s public plea with a simple but assertive message: “On it!”—a gesture that quickly caught national attention and drew praise from those who value leadership that acts instead of postures.

Adams Says He’s ‘Declining Fast’ While Waiting On Treatment

Earlier this year, the 67-year-old Adams shared that his prostate cancer had metastasized to his bones, a condition that often causes severe pain and rapidly deteriorating health. Despite being approved to receive the FDA-sanctioned drug Pluvicto, Adams claims his healthcare provider, Kaiser of Northern California, had dropped the ball on scheduling the essential IV treatment.

Frustrated with delays and mounting health risks, Adams turned to X (formerly Twitter) and made a direct appeal to Trump. “On Monday, I will ask President Trump, via X, to help save my life. He offered to help me if I needed it. I need it,” Adams wrote, with raw honesty and urgency.

He added, “I am declining fast. I will ask President Trump if he can get Kaiser of Northern California to respond and schedule it for Monday. That will give me a fighting chance to stick around on this planet a little bit longer.”

Trump Responds While HHS Gets Involved

Trump’s reply came swiftly, and along with screenshots of Adams’s posts, he made clear that he was taking action. Meanwhile, Health and Human Services Secretary Robert F. Kennedy followed suit, publicly asking Adams, “Scott. How do I reach you? The President wants to help.”

This isn’t campaign theater or vague promises from a podium. It’s a real-time response to help someone facing a life-threatening crisis—precisely the type of leadership many Americans have come to expect from Trump, and miss elsewhere.

At a time when federal bureaucracy and “public health experts” are often criticized for their red tape and political posturing, this direct line of communication wasn’t just refreshing—it was life-affirming.

Kaiser Claims Treatment Is Already Underway

In response to the public backlash, Kaiser Permanente issued a formal statement claiming plans for Adams’s treatment were already advancing. “Mr. Adams’ oncology team is working closely with him on the next steps in his cancer care, which are already underway,” the statement read.

The statement went on to defend their experience with Pluvicto (referred to by its formal abbreviation, Lu-177 PSMA), noting they’ve treated over 150 patients with the therapy in Northern California since the FDA approved it three years ago.

If that’s true, the obvious question becomes—why the delay in Adams’s case? This wasn’t about a regulatory holdup or insurance denial. The treatment had been greenlit. The system allegedly hadn’t scheduled it.

A Troubled System And A Ticking Clock

For Adams, every day without treatment means worsening odds, and the sense of urgency has become undeniable. “It is not a cure,” he said of Pluvicto, “but it does give good results to many people.” In other words, it’s a fighting chance—if only bureaucracy doesn’t smother it.

The irony is striking: the same health system that prides itself on equity and innovation sometimes fails at delivering the most basic need—timely care. And in this case, it took a former president to make the phone ring.

It’s a story that reveals the deep cracks in our healthcare process, where permission and capability aren’t always followed by action, especially for patients who don't fit the preferred political narrative.

A Familiar Name With A Divided Reputation

Adams, a long-time supporter of Trump, has never been a stranger to controversy. He’s drawn heat for opinions outside the mainstream, but what critics frame as “provocative,” others admire as honest.

Even in the midst of his own battle, Adams showed grace, noting that his diagnosis came soon after former President Joe Biden faced a similar health challenge. “I’d like to extend my respect and compassion and sympathy for the ex-president and his family, because they’re going to be going through an especially tough time,” Adams said at the time.

This is not a man looking for pity—it’s someone looking for a fighting chance, and asking for help in the only way that seems to get results anymore: loud and public.

An Ongoing Fight For More Than One Life

Yes, Adams’s illness is personal. But this story casts a wider shadow over how access to health care can hinge not just on insurance, but on influence. How many Americans without a megaphone or mutual contacts are left waiting in silence?

And while critics may scoff at the idea of a former president acting as a private advocate, it’s precisely this kind of hands-on involvement that cuts through the noise—and sometimes saves lives.

The story of Scott Adams and Donald Trump is still unfolding, but one thing is already clear: when system delays meet determined voices, the right kind of pressure can still shake loose progress.